High numbers of CD163+ tumor-associated macrophages correlate with poor prognosis in multiple myeloma patients receiving bortezomib-based regimens

The prognostic significance of tumor-associated macrophages (TAMs) in multiple myeloma (MM) in the era of novel drugs remains unclear. CD163 expression was detected by immunohistochemistry to determine the number of TAMs in 198 MM patients receiving bortezomib-based regimens and the data were used t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hua, Hu, Wan-ming, Xia, Zhong-jun, Liang, Yang, Lu, Yue, Lin, Shu-xia, Tang, Hailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603386/
https://www.ncbi.nlm.nih.gov/pubmed/31289595
http://dx.doi.org/10.7150/jca.30102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603386/
https://www.ncbi.nlm.nih.gov/pubmed/31289595
http://dx.doi.org/10.7150/jca.30102

Ejemplares similares